Zanubrutinib for the treatment of chronic lymphocytic leukemia

被引：0
|
作者：
Bruzzese, Antonella [1 ]
Martino, Enrica Antonia [1 ]
Labanca, Caterina [1 ]
Mendicino, Francesco [1 ]
Lucia, Eugenio [1 ]
Olivito, Virginia [1 ]
Neri, Antonino [2 ]
Morabito, Fortunato [3 ]
Vigna, Ernesto [1 ]
Gentile, Massimo [1 ,4 ,5 ]
机构：
[1] Azienda Osped Annunziata, Hematol Unit, Cosenza, Italy
[2] Sci Directorate IRCCS Reggio Emilia, Reggio Emilia, Italy
[3] AO Cosenza, Biotechnol Res Unit, Cosenza, Italy
[4] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy
[5] Azienda Osped Annunziata, Hematol Unit, I-87100 Cosenza, Italy
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2023年 / 24卷 / 13期
关键词：
Zanubrutinb; CLL; therapy; BTKi; precision medicine; IBRUTINIB; OBINUTUZUMAB; VENETOCLAX; DISCONTINUATION;
D O I：
10.1080/14656566.2023.2229734
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1409 / 1413
页数：5
相关论文
共 50 条
  • [1] Zanubrutinib for the treatment of chronic lymphocytic leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Labanca, Caterina
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (14) : 1537 - 1543
  • [2] Zanubrutinib in Chronic Lymphocytic Leukemia
    Liang, Yang
    Gale, Robert P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1719 - 1720
  • [3] Zanubrutinib in Chronic Lymphocytic Leukemia Reply
    Brown, Jennifer R.
    Cohen, Aileen
    Shadman, Mazyar
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1720 - 1721
  • [4] The Use of Zanubrutinib in Chronic Lymphocytic Leukemia
    Brander, Danielle M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (12) : 1 - 4
  • [5] An evaluation of zanubrutinib, a BTK inhibitor, for the treatment of chronic lymphocytic leukemia
    Geethakumari, Praveen Ramakrishnan
    Awan, Farrukh
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (10) : 1039 - 1046
  • [6] Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Javidi-Sharifi, Nathalie
    Brown, Jennifer R.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 201 - 210
  • [7] Zanubrutinib for the treatment of chronic lymphocytic leukemia (Jul 2023, 10.1080/14656566.2023.2232301)
    Bruzzese, A.
    Martino, E. A.
    Labanca, C.
    Esser, Jonas
    Broulikova, Hana Marie
    Bosmans, Judith
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (13) : I - I
  • [8] A Real-World Study of Zanubrutinib Treatment in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Zhu, Huayuan
    Xia, Yi
    Miao, Yi
    Qin, Shuchao
    Wu, Wei
    Qiu, Tonglu
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2023, 142
  • [9] Zanubrutinib, a promising treatment option for treatment-naive patients with chronic lymphocytic leukemia
    Stocker, Nicolas
    HEMATOLOGIE, 2022, 28 (05): : 207 - 207
  • [10] Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia
    Tam, Constantine
    Munoz, Javier
    Cull, Gavin
    Opat, Stephen
    Allewelt, Heather
    Zhang, Xiaoping
    Stern, Jennifer C.
    Hilger, James
    By, Kunthel
    Cohen, Aileen
    Tedeschi, Alessandra
    HEMASPHERE, 2023, 7 (04):
12345